News Cover
Opinion

Looking at ‘repurposing’ medicine: Biocon

Bengaluru-based biotech main Biocon is engaged on a number of fronts — therapeutic vaccines, new medicine and ‘repurposing’ medicines — to deal with the Covid-19 pandemic. The firm, with revenues of over Rs 5,600 crore, hopes to “repurpose” its present novel biologic Itolizumab to deal with problems attributable to Covid-19, whereas one other drug Cytosorb, used for sepsis therapy, might also assist in lowering mortality, its chairperson Kiran Mazumdar-Shaw stated. Biocon is exploring alternatives to collaborate with US firms to develop antibody-based therapeutic vaccines by way of Indian-American oncologist Siddhartha Mukherjee, she informed TOI. Excerpts:

Several pharma firms are utilizing present medicine to see in the event that they work for Covid-19. Is Biocon “repurposing” medicine from its portfolio?

We are working to repurpose our novel monoclonal antibody Itolizumab (utilized in psoriasis) to deal with problems attributable to Covid-19 an infection. If we will efficiently set up the potential position for our molecule in treating Covid-19 problems, it can allow us to handle a vital unmet want.

In addition, Cytosorb, a product that Biocon has licensed from a US firm, has lately been accredited by the USFDA for emergency therapy of Covid-19. Cytosorb — launched in India for sepsis therapy in 2013 — is a protected and well-tolerated progressive remedy for managing cytokine storm in critically-ill sufferers. We hope that it’ll assist in bringing down mortality in Covid-19 sufferers as nicely.

Biocon is known to have partnered famous oncologist Siddhartha Mukherjee for growing Covid-19 medicine. Are these plasma-derived therapies or anti-virals?

By way ofMukherjee, we’re involved with a number of US firms growing antibody-based therapeutic vaccines. We wish to discover alternatives to collaborate with these US firms to develop these antibody-based vaccines collectively. There is not any formal tie-up as but.

What is the standing of check kits which Biocon’s subsidiary Syngene is growing? Are these antibody testing kits or PCR ones?

At Syngene, my group is engaged on growing PCR-based diagnostic in addition to a serological antibody testing kits. Serological testing can be utilized to detect antibodies current within the blood to determine the true variety of folks in a inhabitants who’ve are available in contact with the Covid-19 virus.

This check can truly additionally determine individuals who could not even have proven any signs and recovered. If serologic testing may be carried out on a lot of folks throughout the nation, it will additionally reveal if India as a rustic has developed ‘herd immunity’ in opposition to the illness, it can give the federal government a key information matrix to regularly carry curfews lockdown from particular areas.

Related posts

Leave a Comment